<DOC>
	<DOCNO>NCT00220961</DOCNO>
	<brief_summary>The purpose study examine whether pioglitazone versus placebo reduce conversion rate impair glucose tolerance ( IGT ) type 2 diabetes mellitus</brief_summary>
	<brief_title>Actos Now Prevention Diabetes ( ACT NOW )</brief_title>
	<detailed_description>IGT prediabetic state . If IGT prevent progress overt diabetes , hyperglycemia-related complication devastate disease prevent . Subjects IGT identify oral glucose tolerance test ( OGTT ) . Eligible subject also measurement first phase insulin secretion insulin sensitivity use frequently sample intravenous glucose tolerance test ( FSIVGTT ) carotid intimal medium thickness use carotid ultrasound . Following measurement subject randomize receive pioglitazone placebo return every 3 month determination fast plasma glucose ( FPG ) concentration interim medical history . Recruitment take place 15 month . From time recruitment period end , subject follow total 24 month pioglitazone placebo . The OGTT repeat 15,27 , 39 month , FPG â‰¥ 126 mg/dl 3-month follow visit . If diagnosis diabetes establish month 39 month 39 , FSIVGTT carotid ultrasound repeat . At 39 month , subject wash pioglitazone placebo OGTT , FSIVGTT , carotid ultrasound repeat month 45 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Men woman All ethnic group 18 year age old Impaired glucose tolerance glucose tolerance test ( fast glucose 95125 mg/dl 2 hr glucose 140199 mg/dl ) At least one following : One component insulin resistance syndrome ( HDL &lt; 40 mg/dl female &lt; 35 mg/dl male , fast triglyceride &gt; 150 mg/dl , blood pressure &gt; 135/85 mmHg , BMI &gt; 24 kg/m2 , waist circumference &gt; 102 cm men &gt; 88 cm woman ) One first degree relative type 2 diabetes History gestational diabetes Polycystic ovarian disease Minority ethnic background ( Mexican American , African American , Asian Pacific Islanders , Native American ) Type 2 diabetes Previously treat thiazolidinediones ( ever ) metformin ( within one year ) Previously treat sulfonylurea , meglitinide , alpha glucosidase inhibitor week within last year within 3 month prior randomization Previously treat insulin ( pregnancy ) one week within last year within 3 month prior randomization Cardiovascular disease Hospitalization treatment heart disease stroke past 6 month New York Heart Association Functional Class &gt; 2 Left bundle branch block third degree AV block Aortic stenosis SBP &gt; 180 mmHg DBP &gt; 105 mmHg Renal disease Anemia Hepatitis GI disease ( pancreatitis , inflammatory bowel disease ) Recent significant abdominal surgery Advanced pulmonary disease Chronic infection Weight loss &gt; 10 % past 6 month Pregnancy childbearing Major psychiatric disorder Excessive alcohol intake Thiazide use &gt; 25 mg per day Nonselective beta blocker Niacin Systemic glucocorticoid Weight loss weight gain medication Thyroid diseasesuboptimally treat Active endocrine disease ( Cushing 's , acromegaly ) Plasma triglycerides 400 mg/dl ( despite treatment ) History bladder cancer Hematuria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Impaired Glucose Tolerance</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Prevention</keyword>
	<keyword>Pioglitazone</keyword>
</DOC>